Hungarians conduct COVID drug experiments in space (article in Hungarian)

The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences’ Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full, and therefore not temporary, and emergency license from the U.S. Food and Drug Administration (FDA) in October 2020…

….

Hungarian InnoStudio Zrt., Which is the leading international player in space chemistry as a new industry and CycloLab Kft., The primary European manufacturer of the excipient of remdesivir, is the first in the world to investigate the possible effects of microgravity during the remdesivir-SBECD interaction.

Read the full Hungarian article on 24.hu

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

Drug Discovery in Space  Webinar Series 2021-2022

Drug Discovery in Space
Webinar Series 2021-2022

It is our pleasure to announce that Japan Manned Space Systems Corporation and InnoStudio are organizing the first ever webinar series dedicated to pharmaceutical research and drug discovery in space. The three-part webinar series, with both scientific and...

Latest Articles